Energeia AS
F:F62
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Energeia AS
F:F62
|
NO |
|
Cizzle Biotechnology Holdings PLC
F:E7F0
|
UK |
|
GMO Payment Gateway Inc
F:3RH
|
JP |
|
China High Speed Transmission Equipment Group Co Ltd
F:BGR
|
HK |
|
A
|
ADENTRA Inc
F:UQ0
|
CA |
|
S2Medical AB (publ)
F:S21
|
SE |
|
S
|
Swiss Properties Invest A/S
F:SR1
|
DK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is F62's stock price target?
Not Available
F62 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Energeia AS?
Projected CAGR
13%
Over the last 3 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 2 years is 13%.